Cybeats Addresses Widespread ‘Log4j’ Vulnerability
Toronto, Ontario--(Newsfile Corp. - December 17, 2021) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (OTCQB: RYMDF) (FSE: EIY2) ("Scryb'' or the "Company") provides...
Day: December 17, 2021
ZEPP HEALTH REPORTS SURGE IN GLOBAL SHIPMENTS IN Q3 2021
CUPERTINO, Calif., Dec. 17, 2021 /PRNewswire/ -- Zepp Health (NYSE: ZEPP) continued its robust growth in global adult watch shipments in...
Force Therapeutics Appoints Greg Andreola as New Chief Revenue Officer
NEW YORK, Dec. 17, 2021 /PRNewswire/ -- Force Therapeutics, the leading patient engagement platform and research network, announced today that...
Big Data Analytics in Healthcare Market to Reach US$ 194.7 Bn Amid Growing Emphasis on Patient Data Security
NEW YORK, Dec. 17, 2021 /PRNewswire/ -- The global big data analytics in healthcare market size is projected to reach a valuation...
ixlayer Wins Silver in 11th Annual Best in Biz Awards
SAN FRANCISCO, Dec. 17, 2021 /PRNewswire/ -- ixlayer has been named a Silver winner for Most Innovative Company of the Year...
Sonesta achieves Sharecare Health Security VERIFIED designation across North American portfolio
ATLANTA, Dec. 17, 2021 /PRNewswire/ -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health...
Redica Systems Announces $30M Series B Led by Savant Growth to Bring New Analytics and Compliance Platform to FDA-Regulated Life Sciences Companies
PLEASANTON, Calif., Dec. 17, 2021 /PRNewswire/ -- Redica Systems, a cloud-based data intelligence platform serving FDA-regulated industries, announced it has...
Sparta Confirms Iconic Ste. Anne’s Spa Will Utilize Its Safe Entry Technology
TORONTO, ON / ACCESSWIRE / December 17, 2021 / Sparta Group (TSX.V:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital",...
Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update
PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
NEW YORK and CLEVELAND, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
CohBar Announces Changes to its Board of Directors and R&D Leadership
Founding board members transition to reconstituted Scientific Advisory Board Kent Grindstaff, Ph.D. appointed as Senior Vice President of Research MENLO...
Todos Medical Announces “Test & Tollovid®” Holiday Package for Atlanta Area at Provista Diagnostics
Todos Test & Tollovid Holiday Package New York, NY, and Tel Aviv, ISRAEL, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis
Phase 2 results provide clinically meaningful reduction in pulmonary vascular resistance; Company intends to design multi-dose Phase 2b trial Treatment...
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
LONDON and SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR)...
C4 Therapeutics Added to NASDAQ Biotechnology Index
WATERTOWN, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company pioneering a...
LifeSci Partnering & Analytics Announces Business Combination with Corsica Life Sciences and Launch of LifeSci Consulting
Business combination with Corsica adds expertise in commercial strategy and market access to established strategy consulting and transaction advisory capabilitiesNEW...
Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial
IND filing achieved ahead of schedule; dosing of first patient in THUNDERBBOLT-1 Phase 1 clinical trial in recurrent GBM anticipated in...
Aquestive Therapeutics Added to NASDAQ Biotechnology Index
WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and...
Advaxis to Continue to Explore Additional Options to Maximize Stockholder Value
Stockholders approved Proposal 1 in support of Biosight merger Proposal 2 reverse stock split, a condition for completing the merger...
Vincerx Pharma Announces First Patient Dosed in Phase 1 Dose-Escalation Study of VIP152 in Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
PALO ALTO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address...